[ad_1]
Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth company less than two months after it started.
[ad_2]
Source link
Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
Published on:
